Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.
/in Dendritic Cells, Glioblastoma, International PublicationsRecent advances in immuno-oncology and its application to urological cancers
/in Dendritic Cells, Hypernephroma, International Publications, Newcastle Disease Virus, Prostate Cancer, Urothelial CarcinomaA feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic CancerDendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic CancerEmerging immunotherapies for glioblastoma
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications, Newcastle Disease VirusImmunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
/in Cervical Cancer, Dendritic Cells, International PublicationsAdjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaDendritic cell-based cancer immunotherapy for colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International PublicationsCancer Vaccines in Ovarian Cancer: How Can We Improve?
/in Dendritic Cells, International Publications, Ovarian Cancer
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer